BIOMAT Database Logo BIOMAT Database Logo

Plasma proinsulin-like component in insulinoma: a 25-year experience. 1995

P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007340 Insulinoma A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA. Adenoma, beta-Cell,Insuloma,beta-Cell Tumor,Adenoma, beta Cell,Adenomas, beta-Cell,Insulinomas,Insulomas,Tumor, beta-Cell,Tumors, beta-Cell,beta Cell Tumor,beta-Cell Adenoma,beta-Cell Adenomas,beta-Cell Tumors
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D018761 Multiple Endocrine Neoplasia Type 1 A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). Neoplasia, Multiple Endocrine Type 1,Neoplasms, Multiple Endocrine Type 1,Wermer Syndrome,Multiple Endocrine Neoplasia Type I,Multiple Endocrine Neoplasms Type 1,Neoplasms, Multiple Endocrine Type I

Related Publications

P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
[Malignant insulinoma with high ratio of proinsulin-like component inside the tumor--a case report].
February 1981, Nihon rinsho. Japanese journal of clinical medicine,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Human insulinoma hybrids produce proinsulin-like material.
December 1982, Diabetes,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Plasma proinsulin-like components.
October 1974, Israel journal of medical sciences,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Fluctuations in plasma proinsulin in an insulinoma. Implications for screening test.
July 1992, Diabetes care,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Plasma antiepileptic drug monitoring in a neurological practice: a 25-year experience.
October 1994, Therapeutic drug monitoring,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Tympanomastoidectomy. A 25-year experience.
January 1983, The Annals of otology, rhinology, and laryngology,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Omphalocele: a 25-year experience.
September 1986, Journal of pediatric surgery,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Plasma proinsulin-like material in insulin treated diabetics.
November 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Treating TTP/HUS with plasma exchange: a single centre's 25-year experience.
October 2008, British journal of haematology,
P Gorden, and M C Skarulis, and P Roach, and R J Comi, and D L Fraker, and J A Norton, and H R Alexander, and J L Doppman
Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states.
October 1974, Diabetologia,
Copied contents to your clipboard!